scholarly journals 13C NMR analysis reveals a link between L-glutamine metabolism, D-glucose metabolism and ?-glutamyl cycle activity in a clonal pancreatic beta-cell line

Diabetologia ◽  
2003 ◽  
Vol 46 (11) ◽  
pp. 1512-1521 ◽  
Author(s):  
L. Brennan ◽  
M. Corless ◽  
C. Hewage ◽  
J. P. G. Malthouse ◽  
N. H. McClenaghan ◽  
...  
Keyword(s):  
Glucose Metabolism ◽  
Beta Cell ◽  
Cell Line ◽  
13C Nmr ◽  
Pancreatic Beta Cell ◽  
Glutamine Metabolism ◽  
Nmr Analysis ◽  
13C Nmr Analysis ◽  
Beta Cell Line

scholarly journals Pancreatic beta cell line MIN6 exhibits characteristics of glucose metabolism and glucose-stimulated insulin secretion similar to those of normal islets

Diabetologia ◽  
1993 ◽  
Vol 36 (11) ◽  
pp. 1139-1145 ◽  
Author(s):  
H. Ishihara ◽  
T. Asano ◽  
K. Tsukuda ◽  
H. Katagiri ◽  
K. Inukai ◽  
...  
Keyword(s):  
Insulin Secretion ◽  
Glucose Metabolism ◽  
Beta Cell ◽  
Cell Line ◽  
Pancreatic Beta Cell ◽  
Beta Cell Line ◽  
Glucose Stimulated Insulin Secretion

The betaHC-9 pancreatic beta-cell line preserves the characteristics of progenitor mouse islets

Diabetes ◽  
1996 ◽  
Vol 45 (12) ◽  
pp. 1766-1773 ◽  
Author(s):  
M. Noda ◽  
M. Komatsu ◽  
G. W. Sharp
Keyword(s):  
Beta Cell ◽  
Cell Line ◽  
Pancreatic Beta Cell ◽  
Beta Cell Line ◽  
Mouse Islets

scholarly journals Regulated expression and function of the GABAB receptor in human pancreatic beta cell line and islets

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Latif Rachdi ◽  
Alicia Maugein ◽  
Severine Pechberty ◽  
Mathieu Armanet ◽  
Juliette Hamroune ◽  
...  
Keyword(s):  
Beta Cell ◽  
Cell Line ◽  
Gabab Receptor ◽  
Pancreatic Beta Cell ◽  
Beta Cell Line ◽  
Regulated Expression ◽  
And Function

Functional analysis of a conditionally transformed pancreatic beta-cell line

Diabetes ◽  
1998 ◽  
Vol 47 (9) ◽  
pp. 1419-1425 ◽  
Author(s):  
N. Fleischer ◽  
C. Chen ◽  
M. Surana ◽  
M. Leiser ◽  
L. Rossetti ◽  
...  
Keyword(s):  
Functional Analysis ◽  
Beta Cell ◽  
Cell Line ◽  
Pancreatic Beta Cell ◽  
Beta Cell Line

scholarly journals High dose of histone deacetylase inhibitors affects insulin secretory mechanism of pancreatic beta cell line

2018 ◽  
Vol 52 (1) ◽  
pp. 21-26 ◽  
Author(s):  
Eiji Yamato
Keyword(s):  
Insulin Secretion ◽  
Beta Cell ◽  
Cell Line ◽  
Beta Cells ◽  
Pancreatic Beta Cells ◽  
Pancreatic Beta Cell ◽  
High Dose ◽  
Min6 Cells ◽  
Beta Cell Line ◽  
High Doses

Abstract Objective. Histone deacytylase inhibitors (HDACis) inhibit the deacetylation of the lysine residue of proteins, including histones, and regulate the transcription of a variety of genes. Recently, HDACis have been used clinically as anti-cancer drugs and possible anti-diabetic drugs. Even though HDACis have been proven to protect the cytokine-induced damage of pancreatic beta cells, evidence also shows that high doses of HDACis are cytotoxic. In the present study, we, therefore, investigated the eff ect of HDACis on insulin secretion in a pancreatic beta cell line. Methods. Pancreatic beta cells MIN6 were treated with selected HDACis (trichostatin A, TSA; valproic acid, VPA; and sodium butyrate, NaB) in medium supplemented with 25 mM glucose and 13% heat-inactivated fetal bovine serum (FBS) for indicated time intervals. Protein expression of Pdx1 and Mafa in MIN6 cells was demonstrated by immunohistochemistry and immunocytochemistry, expression of Pdx1 and Mafa genes was measured by quantitative RT-PCR method. Insulin release from MIN6 cells and insulin cell content were estimated by ELISA kit. Superoxide production in MIN6 cells was measured using a Total ROS/Superoxide Detection System. Results. TSA, VPA, and NaB inhibited the expression of Pdx1 and Mafa genes and their products. TSA treatment led to beta cell malfunction, characterized by enhanced insulin secretion at 3 and 9 mM glucose, but impaired insulin secretion at 15 and 25 mM glucose. Th us, TSA induced dysregulation of the insulin secretion mechanism. TSA also enhanced reactive oxygen species production in pancreatic beta cells. Conclusions. Our results showed that HDACis caused failure to suppress insulin secretion at low glucose concentrations and enhance insulin secretion at high glucose concentrations. In other words, when these HDACis are used clinically, high doses of HDACis may cause hypoglycemia in the fasting state and hyperglycemia in the fed state. When using HDACis, physicians should, therefore, be aware of the capacity of these drugs to modulate the insulin secretory capacity of pancreatic beta cells.

scholarly journals Identification of genes regulated by glucose in a pancreatic beta-cell line by a new method for subtraction of mRNA

Diabetologia ◽  
1996 ◽  
Vol 39 (11) ◽  
pp. 1293-1298 ◽  
Author(s):  
E. Yamato ◽  
H. Ikegami ◽  
J.-I. Miyazaki ◽  
T. Ogihara
Keyword(s):  
Beta Cell ◽  
Cell Line ◽  
Pancreatic Beta Cell ◽  
New Method ◽  
Beta Cell Line
Sign in / Sign up

Export Citation Format

Share Document